Dyne Therapeutics’ Post

The application of platform, enrichment and adaptive designs can deliver innovative therapies to patients, faster and more efficiently. My colleague Cecil Nick, VP (Technical) Parexel Regulatory Strategy explores how we can advance clinical development through innovative trial design, with intensive planning and close interaction with regulatory agencies. Find out more about platform trials, basket trials, umbrella trials, enrichment designs, and adaptive trials – with practical examples of each, and their application in different therapeutic areas, in this new white paper.

The application of platform, enrichment and adaptive designs can deliver innovative therapies to patients, faster and more efficiently. My colleague Cecil Nick, VP (Technical) Parexel Regulatory Strategy explores how we can advance clinical development through innovative trial design, with intensive planning and close interaction with regulatory agencies. Find out more about platform trials, basket trials, umbrella trials, enrichment designs, and adaptive trials – with practical examples of each, and their application in different therapeutic areas, in this new white paper.

The application of platform, enrichment and adaptive designs can deliver innovative therapies to patients, faster and more efficiently. My colleague Cecil Nick, VP (Technical) Parexel Regulatory Strategy explores how we can advance clinical development through innovative trial design, with intensive planning and close interaction with regulatory agencies. Find out more about platform trials, basket trials, umbrella trials, enrichment designs, and adaptive trials – with practical examples of each, and their application in different therapeutic areas, in this new white paper.

The application of platform, enrichment and adaptive designs can deliver innovative therapies to patients, faster and more efficiently. My colleague Cecil Nick, VP (Technical) Parexel Regulatory Strategy explores how we can advance clinical development through innovative trial design, with intensive planning and close interaction with regulatory agencies. Find out more about platform trials, basket trials, umbrella trials, enrichment designs, and adaptive trials – with practical examples of each, and their application in different therapeutic areas, in this new white paper.

The application of platform, enrichment and adaptive designs can deliver innovative therapies to patients, faster and more efficiently. My colleague Cecil Nick, VP (Technical) Parexel Regulatory Strategy explores how we can advance clinical development through innovative trial design, with intensive planning and close interaction with regulatory agencies. Find out more about platform trials, basket trials, umbrella trials, enrichment designs, and adaptive trials – with practical examples of each, and their application in different therapeutic areas, in this new white paper.

A Phase 1 clinical trial aims to assess the drug’s safety and dosage and enable the design of Phase 2 and the rest of the clinical trial phases. Here's what you need to know about designing a successful phase 1 clinical trial: https://lnkd.in/gpQ2z4UB

Inclusivity and innovation in clinical trials is more important than ever as clinical trials are rapidly evolving. Julie Ross, our President & CEO, was interviewed in a recent publication affiliated with Newsweek, where she shared insights into the clinical trial industry. Read the interview: https://hubs.la/Q02n5nXw0 #BetterClinicalExperience #CRO #ClinicalResearch #StrategicResourcing

☝️ Don’t miss this: FGK Managing Director Martin Krauss will be speaking at the DGRA e.V. Annual Congress on June 20-21, 2024, in the historic former Assembly Room of the German Bundestag in Bonn. His presentation, titled "Clinical Trials," will address the key challenges in #clinicalresearch, with a special focus on Germany.   For more details and registration info, check the comments below! 👇   #wefeelresponsible #clinicaltrial #CRO

Inclusivity and innovation in clinical trials is more important than ever as clinical trials are rapidly evolving. Julie Ross, our President & CEO, was interviewed in a publication affiliated with Newsweek, where she shared insights into the clinical trial industry. Read the interview: https://hubs.la/Q02J6mWN0 #BetterClinicalExperience #CRO #ClinicalResearch #StrategicResourcing

Hurry! Get your free guide to Finding Top Clinical Research Organizations in 2024 Now! Find out what questions you should be asking and discover the top indicators reshaping the clinical research landscape in our latest blog – "Managing Efficient Clinical Trials with CROs: Guide to Finding Top Clinical Research Organizations in 2024." This is your MUST HAVE guide to clinical trial excellence. Read the Blog Now: https://lnkd.in/gCqjEFyw Sowmya Kaur, Yun Lu, Sarah Woody Lawrence #cro #topcro #globalcollaboration